Contemporaneous and upcoming trends in immunotherapy for prostate cancer: review

Prostate cancer (PCa) is the most common cancer in men worldwide. It affects more than 1.4 million men worldwide and kills up to 37 5000 people. PCa is routinely managed with chemotherapy and androgen deprivation therapy, but the success rate of these treatments is unsatisfactory. Immunotherapy is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleem, Samra, Rashid, Abu B., Shehzadi, Sarma, Mumtaz, Hassan, Saqib, Muhammad, Bseiso, Anan, Villasenor, Alexis V., Ahmed, Adeel, Sonia, Shamsun N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406079/
https://www.ncbi.nlm.nih.gov/pubmed/37554896
http://dx.doi.org/10.1097/MS9.0000000000001070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406079/
https://www.ncbi.nlm.nih.gov/pubmed/37554896
http://dx.doi.org/10.1097/MS9.0000000000001070

Ejemplares similares